# Study on the Treatment of Advanced Malignant Solid Tumor With Revottack and PD-1 Inhibitor

> **NCT05644509** · PHASE1 · UNKNOWN · sponsor: **The Affiliated Hospital of Xuzhou Medical University** · enrollment: 10 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **BIOLOGICAL:** Oncolytic Virus Injection（Revottack）+PD-1

## Key facts

- **NCT ID:** NCT05644509
- **Lead sponsor:** The Affiliated Hospital of Xuzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2022-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05644509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05644509, "Study on the Treatment of Advanced Malignant Solid Tumor With Revottack and PD-1 Inhibitor". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05644509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*